Cita APA (7a ed.)
Li, X., Huang, L., Cai, H., Huang, W., & Huang, X. (2022). First‐line or second‐line PD‐1 inhibition in advanced oesophageal squamous cell carcinoma: A prospective, multicentre, registry study. Journal of Clinical Pharmacy & Therapeutics, 47(6), 732-738.
Cita Chicago Style (17a ed.)
Li, Xu‐Yuan, Li‐Sheng Huang, Hao‐Quan Cai, Wan‐Lan Huang, y Xiao‐Long Huang. "First‐line or Second‐line PD‐1 Inhibition in Advanced Oesophageal Squamous Cell Carcinoma: A Prospective, Multicentre, Registry Study." Journal of Clinical Pharmacy & Therapeutics 47, no. 6 (2022): 732-738.
Cita MLA (9a ed.)
Li, Xu‐Yuan, et al. "First‐line or Second‐line PD‐1 Inhibition in Advanced Oesophageal Squamous Cell Carcinoma: A Prospective, Multicentre, Registry Study." Journal of Clinical Pharmacy & Therapeutics, vol. 47, no. 6, 2022, pp. 732-738.
Precaución: Estas citas no son 100% exactas.